NEPHROS, INC. Increase (Decrease) in Accounts Payable and Other Operating Liabilities
NEPHROS, INC. (NEPH) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2014-05-14
- NEPHROS, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- NEPHROS, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- NEPHROS, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- NEPHROS, INC. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2013-06-30 was -$513.00K.
- NEPHROS, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- NEPHROS, INC. increase (decrease) in accounts payable and other operating liabilities for fiscal 2012 was $1.32M.
| Period end | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 3 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 9 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | -$513.00K derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | -$513.00K derived: sum of 3 quarters · filed 2014-03-28 | $0.00 10-K · filed 2014-03-28 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$513.00K derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $52.00K derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-06-30 | -$513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $0.00 10-Q · filed 2013-08-13 | $52.00K derived: sum of 3 quarters · filed 2014-05-14 | $80.00K derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-03-31 | $513.00K 10-Q · filed 2014-05-14 | $565.00K derived: sum of 2 quarters · filed 2014-05-14 | $593.00K derived: sum of 3 quarters · filed 2014-05-14 | |
| 2012-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $80.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.32M 10-K · filed 2014-03-28 | |
| 2012-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.27M 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $1.24M 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |